scispace - formally typeset
L

Laura N. Brenner

Researcher at Harvard University

Publications -  28
Citations -  519

Laura N. Brenner is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 20 publications receiving 265 citations. Previous affiliations of Laura N. Brenner include Columbia University Medical Center & Columbia University.

Papers
More filters
Journal ArticleDOI

Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.

Lida P. Hariri, +27 more
- 01 Jan 2021 - 
TL;DR: In this paper, the authors conducted a systematic review to characterize the lung histopathologic features of COVID-19 and compare them against findings of other recent viral pandemics, H1N1 influenza and SARS.
Journal ArticleDOI

Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.

Aaron Leong, +8 more
- 04 Mar 2021 - 
TL;DR: In this paper, the associations of 17 cardiometabolic traits with COVID-19 susceptibility and severity using 2-sample Mendelian randomization (MR) analyses were evaluated.
Journal ArticleDOI

The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis

Tom E.F. Abbott, +2654 more
- 01 Jan 2018 - 
TL;DR: Patients exposed to a surgical safety checklist experience better postoperative outcomes, but this could simply reflect wider quality of care in hospitals where checklist use is routine.
Posted ContentDOI

Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis.

Aaron Leong, +5 more
- 01 Sep 2020 - 
TL;DR: Genetic evidence supports BMI as a causal risk factor for COVID-19 susceptibility and severity, and this relationship may be mediated via type 2 diabetes.
Journal ArticleDOI

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis

Sydney B. Montesi, +6 more
- 27 Jan 2014 - 
TL;DR: It is demonstrated that multiple LPA species are detectable in EBC, and that 22:4 LPA levels are elevated in the EBC of IPF patients, as well as its potential to serve as a biomarker for disease severity and/or progression.